|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 504.00 JPY | +1.41% |
|
+4.56% | -7.18% |
| 03-03 | IMPLANET Receives FDA Clearance for the Swingo Anterior Cervical Cage | CI |
| 11-14 | Arima informs on terms of JSS merger | RE |
Company Valuation: JSS Corporation
Data adjusted to current consolidation scope
| Fiscal Period: March | 2025 | 2026 |
|---|---|---|
| Market Cap 1 | 1,695 | 2,045 |
| Change | - | 20.67% |
| Enterprise Value (EV) 1 | 3,138 | 2,986 |
| Change | - | -4.84% |
| P/E | 8.51x | 8.45x |
| PBR | 0.56x | 0.64x |
| PEG | - | 0.4x |
| Capitalization / Revenue | 0.2x | 0.24x |
| EV / Revenue | 0.37x | 0.35x |
| EV / EBITDA | 6.42x | 4.39x |
| EV / EBIT | 12.4x | 6.85x |
| EV / FCF | - | - |
| FCF Yield | - | - |
| Dividend per Share 2 | 17.5 | - |
| Rate of return | 4.16% | - |
| EPS 2 | 49.46 | 60.12 |
| Distribution rate | 35.4% | - |
| Net sales 1 | 8,381 | 8,541 |
| EBITDA 1 | 489 | 680 |
| EBIT 1 | 254 | 436 |
| Net income 1 | 192 | 242 |
| Net Debt 1 | 1,443 | 941 |
| Reference price 2 | 421.00 | 508.00 |
| Nbr of stocks (in thousands) | 4,026 | 4,026 |
| Announcement Date | 6/26/25 | 6/25/26 |
1JPY in Million2JPY
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 12.41M | |
| 19.04x | 3.55x | 11.6x | 1.73% | 10.84B | |
| 20.33x | 2.78x | 10.57x | - | 5.51B | |
| 186.25x | 1.12x | 9.72x | - | 1.89B | |
| 8.32x | 2.47x | 8.24x | 3.58% | 473M | |
| 17.17x | - | - | 0.81% | 352M | |
| 8.44x | - | - | 1.6% | 191M | |
| Average | 43.26x | 2.48x | 10.03x | 1.93% | 2.75B | |
| Weighted average by Cap. | 35.39x | 3.05x | 11.02x | 1.77% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 6074 Stock
- Valuation JSS Corporation
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
